After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Cubist Pharmaceuticals on Tuesday committed up to $1.6 billion to acquire two makers of next-generation antibiotics in a bid to expand aggressively its acute care product portfolio.
Stock futures are little changed Wednesday despite upbeat reports on GDP and jobs ahead of the Fed announcement.
U.S. stock futures suggest a flat to slightly higher start for Wall Street; Cubist Pharmaceuticals makes two acquisitions; MasterCard and Comcast highlight the earnings calendar.
Cubist announces two acquisitions in one day.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.